Outcomes of COVID-19 infection in patients with chronic lymphocytic leukemia: a systematic review and meta-analysis
Authors:
- Mohammad Amin AkbarzadehMAMohammad Amin Akbarzadeh
- Yosra Vaez-GharamalekiYVYosra Vaez-Gharamaleki
- Farid JahanshahlouFJFarid Jahanshahlou
- Alireza Ghaffari BavilABAlireza Ghaffari Bavil
- Sina HamzehzadehSHSina Hamzehzadeh
- Sina SeifimansourSSSina Seifimansour
- Alireza Rahimi-MamaghaniARAlireza Rahimi-Mamaghani
- Mohammad-Salar HosseiniMHMohammad-Salar Hosseini
Open Access
- 1 January 2024
- journal article
- review article
- Published by FapUNIFESP (SciELO) in Revista da Associação Médica Brasileira
- Vol. 70 (8) , e20240322
Abstract
Since the beginning of the COVID-19 pandemic, complications of this disease among vulnerable populations have been a primary concern. Cancer patients are among the most vulnerable groups of patients owing to the compromised immune system and weakened overall health status1 1 Akbarzadeh MA, Hosseini MS. Implications for cancer care in Iran during COVID-19 pandemic. Radiother Oncol. 2020;148:148:211-2. https://doi.org/10.1016/j.radonc.2020.04.041 https://doi.org/10.1016/j.radonc.2020.04... .Keywords
This publication has 37 references indexed in Scilit:
- Formulating research questions for evidence-based studiesJournal of Medicine, Surgery, and Public Health, 2023
- The evolving landscape of COVID‐19 and post‐COVID condition in patients with chronic lymphocytic leukemia: A study by ERIC, the European research initiative on CLLAmerican Journal of Hematology, 2023
- Febrile neutropenia: Clinical approach to a controversial presentation of the COVID-19 eraJournal of the National Cancer Center, 2023
- Clinical Outcomes in Patients With COVID-19 and Hematologic DiseaseClinical Lymphoma Myeloma and Leukemia, 2023
- COVID-19 in patients with chronic lymphocytic leukemia: a multicenter analysis by the Czech CLL study groupAnnals of Hematology, 2023
- SARS‐CoV‐2 infection in patients with chronic lymphocytic leukemia: The Italian Hematology Alliance on COVID‐19 cohortHematological Oncology, 2022
- The outcome of COVID-19 in patients with hematological malignancymemo - Magazine of European Medical Oncology, 2021
- Management of chronic lymphocytic leukemia in Italy during a one year of the COVID‐19 pandemic and at the start of the vaccination program. A Campus CLL reportHematological Oncology, 2021
- Ibrutinib for chronic lymphocytic leukemia in the setting of respiratory failure from severe COVID‐19 infection: Case report and literature revieweJHaem, 2020
- Implications for cancer care in Iran during COVID-19 pandemicRadiotherapy and Oncology, 2020